Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Moodys
AstraZeneca
Express Scripts
Harvard Business School
Medtronic
McKinsey

Last Updated: October 22, 2019

DrugPatentWatch Database Preview

NUTROPIN Drug Profile

See Plans and Pricing

« Back to Dashboard

Which patents cover Nutropin, and when can generic versions of Nutropin launch?

Nutropin is a drug marketed by Genentech and is included in three NDAs.

The generic ingredient in NUTROPIN is somatropin recombinant. There are four drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the somatropin recombinant profile page.

Drug patent expirations by year for NUTROPIN
Drug Prices for NUTROPIN

See drug prices for NUTROPIN

Recent Clinical Trials for NUTROPIN

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Genentech, Inc.Phase 4
Center for Human ReproductionPhase 1/Phase 2
Novo Nordisk A/SPhase 1

See all NUTROPIN clinical trials

US Patents and Regulatory Information for NUTROPIN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Genentech NUTROPIN somatropin INJECTABLE;INJECTION 020168-001 Nov 17, 1993 DISCN No No   Start Trial   Start Trial   Start Trial
Genentech NUTROPIN AQ PEN somatropin INJECTABLE;INJECTION 020522-002 Apr 22, 2002 DISCN Yes No   Start Trial   Start Trial   Start Trial
Genentech NUTROPIN AQ NUSPIN somatropin INJECTABLE;INJECTION 020522-003 Jan 3, 2008 RX Yes Yes   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
AstraZeneca
Medtronic
Harvard Business School
Moodys
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.